Literature DB >> 20096390

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

Olivia J White1, Julie Rowe, Peter Richmond, Helen Marshall, Peter McIntyre, Nicholas Wood, Patrick G Holt.   

Abstract

Current infant vaccination against pertussis in North America and Australia requires three doses of vaccines including diphtheria, tetanus and acellular pertussis antigens (DTaP) at 2, 4 and 6 months of age. Interest is growing in the possibility that vaccination at birth might provide earlier protection of infants, but early vaccination also gives rise to concerns over the potential for excessive Th2-polarisation of pertussis-specific T-cell memory profiles. We evaluated this issue as part of a small pilot study comparing infants receiving a monovalent acellular pertussis vaccine (aP) at birth or birth and at 1 month, followed by DTaP at 2, 4 and 6 months with infants receiving DTaP only from 2 months. We compared in vitro Th-memory responses at 8 months and pertussis-specific IgG in serum at 2, 4, 6 and 8 months. Neonatal vaccination elicited earlier IgG responses, but accompanying Th-memory profiles displayed a strong Th2 bias with high IL-5 and IL-13 production. The correlation between T-cell memory profiles and other clinical outcomes should be evaluated in larger trials of neonatal aP vaccine. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096390     DOI: 10.1016/j.vaccine.2010.01.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

Review 2.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

Authors:  Jeanet M Kemmeren; Nicoline At van der Maas; Hester E de Melker
Journal:  Eur J Pediatr       Date:  2017-04-20       Impact factor: 3.183

4.  Development of newborn and infant vaccines.

Authors:  Guzman Sanchez-Schmitz; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

5.  Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease.

Authors:  Cynthia A Leifer; Rodney R Dietert
Journal:  Toxicol Environ Chem       Date:  2011       Impact factor: 1.437

Review 6.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 7.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

Authors:  S K Sharma; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

9.  Noninvasive vaccination as a casus belli to redeem vaccine value in the face of anti-vaccine movements.

Authors:  De-Chu C Tang
Journal:  Integr Mol Med       Date:  2017-07-24

Review 10.  Challenges in vaccination of neonates, infants and young children.

Authors:  Michael E Pichichero
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.